Are you Dr. Bensinger?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 55 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
11311 Bridgeport Way SW Ste 302
Lakewood, WA 98499Phone+1 253-533-6700Fax+1 253-584-1271- Is this information wrong?
Summary
- Dr. William Bensinger, MD is an oncologist in Lakewood, Washington. He is currently licensed to practice medicine in Washington and Alaska. He is affiliated with Swedish First Hill Campus and UW Medicine/University of Washington Medical Center.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1973 - 1974
Northwestern University The Feinberg School of MedicineClass of 1973
Certifications & Licensure
WA State Medical License 1976 - 2025
AK State Medical License 2021 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma Start of enrollment: 1997 Nov 01
- Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma Start of enrollment: 1997 Dec 01
- Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma Start of enrollment: 1999 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsSelinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies.Gary J Schiller, Brea C Lipe, Nizar J Bahlis, Sascha A Tuchman, William I Bensinger, Heather J Sutherland, Suzanne Lentzsch, Muhamed Baljevic, Darrell White, Rami Kotb...> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Sep 1
- 10 citationsSelinexor-based regimens in patients with multiple myeloma after prior anti-B-cell maturation antigen treatment.Muhamed Baljevic, Cristina Gasparetto, Gary J Schiller, Sascha A Tuchman, Natalie S Callander, Suzanne Lentzsch, Jorge Monge, Rami Kotb, Nizar J Bahlis, Darrell White,...> ;Ejhaem. 2022 Nov 1
- 7 citationsDaratumumab, cyclophosphamide, bortezomib, and dexamethasone for multiple myeloma: final results of the LYRA study.Habte Yimer, Jason Melear, Edward Faber, William I Bensinger, John M Burke, Mohit Narang, Don Stevens, Kathleen S Gray, Yana Lutska, Padma Bobba, Keqin Qi, Daniela Hoe...> ;Leukemia & Lymphoma. 2022 Oct 1
- Join now to see all
Press Mentions
Trials Investigate Novel Agents, Autologous Stem Cell Transplantation for Newly Diagnosed Multiple MyelomaJune 4th, 2016
Grant Support
- Targeted Radiotherapy With 90y-Bc8 Monclonal Antibody, Fludarabine And TBI FollowNational Cancer Institute2011
- Autologous Morrow TransplantationNational Cancer Institute1996
- In Vitro Detection Of Residual LeukemiaNational Cancer Institute1989–1991
- Autologous Marrow Transplantation For Multiple MyelemalNational Cancer Institute1989–1991
- Transfusion Support--CoreNational Cancer Institute1987–1991
- Platelet Alloimmunity In Marrow TransplantationNational Cancer Institute1987–1991
Hospital Affiliations
UW Medicine/University of Washington Medical CenterSeattle, Washington
Swedish First Hill CampusSeattle, Washington
